Accel Wealth Management’s PetMed Express PETS Stock Holding History

Accel Wealth Management’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-300	Closed	-$8K	–	1060
2022 Q1	$8K	Hold	300	–	–	﹤0.01%	744
2021 Q4	$8K	Hold	300	–	–	﹤0.01%	747
2021 Q3	$8K	Hold	300	–	–	0.01%	681
2021 Q2	$10K	Buy	+300	New	+$9.53K	0.01%	696

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Accel Wealth Management's PETS Position: Q2 2022 in Review

Accel Wealth Management sold out of PetMed Express (PETS) in Q2 2022, closing a stake of 300 shares — an estimated $8K sold.

Accel Wealth Management first reported a position in PETS in Q2 2021 and held it in 4 quarters. The position peaked at $10K in Q2 2021. 172 funds tracked by Wall St. Rank hold PETS as of Q2 2022.

Accel Wealth Management reported no remaining PetMed Express position as of Q2 2022 after selling out during the quarter.
Accel Wealth Management sold 300 PetMed Express shares in Q2 2022, an estimated $8K.
Accel Wealth Management first reported a position in PetMed Express in Q2 2021 and held it in 4 quarters.
Accel Wealth Management's PetMed Express position peaked at $10K in Q2 2021.
172 funds tracked by Wall St. Rank held PetMed Express as of Q2 2022.

Based on Accel Wealth Management's 13F filing for Q2 2022, filed 3 Aug 2022.